The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Signatures of mutation and selection in the cancer genome
Open accessAbstract
The cancer genome is moulded by the dual processes of somatic mutation and selection. Homozygous deletions in cancer genomes occur over recessive cancer genes, where they can confer selective growth advantage, and over fragile sites, where they are thought to reflect an increased local rate of DNA breakage. However, most homozygous deletions in cancer genomes are unexplained. Here we identified 2,428 somatic homozygous deletions in 746 cancer cell lines. These overlie 11% of protein-coding genes that, therefore, are not mandatory for survival of human cells. We derived structural signatures that distinguish between homozygous deletions over recessive cancer genes and fragile sites. Application to clusters of unexplained homozygous deletions suggests that many are in regions of inherent fragility, whereas a small subset overlies recessive cancer genes. The results illustrate how structural signatures can be used to distinguish between the influences of mutation and selection in cancer genomes. The extensive copy number, genotyping, sequence and expression data available for this large series of publicly available cancer cell lines renders them informative reagents for future studies of cancer biology and drug discovery. Two Articles in this issue add major data sets to the growing picture of the cancer genome. Bignell et al. analysed a large number of homozygous gene deletions in a collection of 746 publicly available cancer cell lines. Combined with information about hemizygous deletions of the same genes, the data suggest that many deletions found in cancer reflect the position of a gene at a fragile site in the genome, rather than as a recessive cancer gene whose loss confers a selective growth advantage. Beroukhim et al. present the largest data set to date on somatic copy-number variations across more than 3,000 specimens of human primary cancers. Many alterations are shared between multiple tumour types. Functional experiments demonstrate an oncogenic role for the apoptosis genes MCL1 and BCL2L1 that are associated with amplifications found in many cancers. Homozygous gene deletions in cancer cells occur over recessive cancer genes (where they can confer selective growth advantage) or over genes at fragile sites of the genome (where they are thought to reflect increased DNA breakage). Here, a large number of homozygous deletions in a collection of cancer cell lines are identified and analysed to derive structural signatures for the two different types of deletion. More deletions are found in inherently fragile regions, and fewer overlying recessive genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“tandem repeat-containing regions we identified co-localized to 9 of 11 (81.8%) of the molecularly mapped rare folate-sensitive fragile sites37, all at CG-containing tandem repeats”
From Genome-wide detection of tandem DNA repeats that are expanded in autism (2020) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function
Melo, S. A., Ropero, S., Moutinho, C., Aaltonen, L. A., Yamamoto, H., Calin, G. A., Rossi, S., Fernández, A. F., Carneiro, F., Oliveíra, C., et al. (2009) · Nature Genetics · doi:10.1038/ng.317 · Cited by 375
RetractedControlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,625
Self-citationThe Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D. L., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,161
Somatic mutations affect key pathways in lung adenocarcinoma
Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., et al. (2008) · Nature · doi:10.1038/nature07423 · Cited by 2,681
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S. D., Wang, J., Myeroff, L. L., Parsons, R. E., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,267
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
Versteege, I., Sévenet, N., Lange, J., Rousseau-Merck, M.-F., Ambros, P. F., Handgretinger, R., Aurias, A., & Delattre, O. (1998) · Nature · doi:10.1038/28212 · Cited by 1,552
Ozawa, M., Baribault, H., & Kemler, R. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03563.x · Cited by 1,396
Flagged first, then by citations
1 of the 41 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 709
Modeling the evolution space of breakage fusion bridge cycles with a stochastic folding process
Greenman, C., Cooke, S. L., Marshall, J., Stratton, M. R., & Campbell, P. J. (2015) · Journal of Mathematical Biology · doi:10.1007/s00285-015-0875-2 · Cited by 16
Self-citationMészáros, B., Zeke, A., Reményi, A., Simon, I., & Dosztányi, Z. (2016) · Biology Direct · doi:10.1186/s13062-016-0125-6 · Cited by 17
VentX trans-Activates p53 and p16ink4a to Regulate Cellular Senescence
Wu, X., Gao, H., Ke, W., Hager, M. H., Xiao, S., Freeman, M. R., & Zhu, Z. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.206078 · Cited by 17
Inferring Cancer Progression from Single-cell Sequencing while Allowing Mutation LossesPreprint
Ciccolella, S., Gomez, M. S., Patterson, M., Vedova, G. D., Hajirasouliha, I., & Bonizzoni, P. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/268243 · Cited by 17
Bhargava, R., Lopezcolorado, F. W., Tsai, L. J., & Stark, J. M. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010421 · Cited by 16
Ng, A. W. T., Contino, G., Killcoyne, S., Devonshire, G., Hsu, R., Abbas, S., Su, J., Redmond, A. M., Weaver, J. M. J., Eldridge, M., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03238-7 · Cited by 15
Estimating linkage disequilibrium and selection from allele frequency trajectories
Li, Y., & Barton, J. P. (2023) · Genetics · doi:10.1093/genetics/iyac189 · Cited by 16
Pressete, C. G., Viegas, F. P. D., Campos, T. G., Caixeta, E. S., Hanemann, J. A. C., Ferreira‐Silva, G. Á., Zavan, B., Aissa, A. F., Miyazawa, M., Viegas, C., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16020145 · Cited by 16
Screens, maps & networks: from genome sequences to personalized medicine
Sandmann, T., & Boutros, M. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.02.001 · Cited by 17
Kato, M., Vasco, D. A., Sugino, R. P., Narushima, D., & Krasnitz, A. (2017) · Royal Society Open Science · doi:10.1098/rsos.171060 · Cited by 18
The Role of Chromosome Deletions in Human Cancers
Chen, M., Yang, Y., Liu, Y., & Chen, C. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0593-1_9 · Cited by 16
Genetic Load and Potential Mutational Meltdown in Cancer Cell Populations
Zhang, Y., Li, Y., Shen, X., Zhu, T., Tao, Y., Tao, Y., Li, X., Wang, D., Ma, Q., Hu, Z., et al. (2018) · Molecular Biology and Evolution · doi:10.1093/molbev/msy231 · Cited by 16
Inferring Tumor Proliferative Organization from Phylogenetic Tree Measures in a Computational Model
Scott, J. G., Maini, P. K., Anderson, A. R. A., & Fletcher, A. G. (2019) · Systematic Biology · doi:10.1093/sysbio/syz070 · Cited by 16
Mirzaei, G., & Petreaca, R. C. (2021) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2021.111773 · Cited by 16
Tumor Suppressor WWOX Contributes to the Elimination of Tumorigenic Cells in Drosophila melanogaster
O’Keefe, L. V., Lee, C. S., Choo, A., & Richards, R. I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136356 · Cited by 16
Penfornis, P., Cai, D. Z., Harris, M. R., Walker, R., Licini, D. J., Fernandes, J. D., Orr, G., Koganti, T., Hicks, C., Induru, S., et al. (2014) · Cancer Medicine · doi:10.1002/cam4.249 · Cited by 16
Portrait of replication stress viewed from telomeres
Ishikawa, F. (2013) · Cancer Science · doi:10.1111/cas.12165 · Cited by 18
Genomic landscape of diffuse glioma revealed by whole genome sequencing
Kinnersley, B., Jung, J., Cornish, A. J., Chubb, D., Laxton, R. C., Frangou, A., Gruber, A. J., Sud, A., Caravagna, G., Sottoriva, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59156-9 · Cited by 18
Suwakulsiri, W., Xu, R., Rai, A., Chen, M., Shafiq, A., Greening, D. W., & Simpson, R. J. (2024) · PROTEOMICS · doi:10.1002/pmic.202300058 · Cited by 12
Discovering Tumor Suppressor Genes Through Genome-Wide Copy Number Analysis
Rothenberg, S. M., & Settleman, J. (2010) · Current Genomics · doi:10.2174/138920210791616734 · Cited by 16
Splice variant PRKC-ζ-PrC is a novel biomarker of human prostate cancer
Yao, S., Ireland, S. J., Bee, A., Beesley, C., Forootan, S. S., Dodson, A. R., Dickinson, T., Gerard, P., Lian, L., Risk, J. M., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.162 · Cited by 15
Brueckner, L. M., Sagulenko, E., Hess, E. M., Zheglo, D., Blumrich, A., Schwab, M., & Savelyeva, L. (2012) · Human Genetics · doi:10.1007/s00439-012-1165-3 · Cited by 15
Statistical model-based testing to evaluate the recurrence of genomic aberrations
Niida, A., Imoto, S., Shimamura, T., & Miyano, S. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts203 · Cited by 15
Polymorphisms in DNA repair genes XRCC2 and XRCC3 risk of gastric cancer in Turkey
Gök, İ., Baday, M., Çetinkünar, S., Kilic, K., & Bilgin, B. Ç. (2014) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2014.4.7 · Cited by 15
ATMIN Is a Tumor Suppressor Gene in Lung Adenocarcinoma
Foster, H., Ruiz, E. J., Moore, C., Stamp, G. W. H., Nye, E. L., Li, N., Pan, Y., He, Y., Downward, J., & Behrens, A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0647 · Cited by 15
Fan, X., Song, J., Fan, Y., Li, J., Chen, Y., Zhu, H., & Zhang, Z. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s338284 · Cited by 15
Preliminary evidence of different selection pressures on cancer cells as compared to normal tissues
Ovens, K. L., & Naugler, C. T. (2012) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-9-44 · Cited by 15
Khalil, A. I. S., Khyriem, C., Chattopadhyay, A., & Sanyal, A. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-3480-3 · Cited by 14
Perez, S., Lavi-Itzkovitz, A., Gidoni, M., Domovitz, T., Dabour, R., Khurana, I., Davidovich, A., Tobar, A., Livoff, A., Solomonov, E., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.03.004 · Cited by 15
Paralog dispensability shapes homozygous deletion patterns in tumor genomes
Kegel, B. D., & Ryan, C. J. (2023) · Molecular Systems Biology · doi:10.15252/msb.202311987 · Cited by 11
Mapping of homozygous deletions in verified esophageal adenocarcinoma cell lines and xenografts
Boonstra, J. J., van Marion, R., Douben, H., Lanchbury, J. S. S., Timms, K. M., Abkevich, V., Tilanus, H. W., de Klein, A., & Dinjens, W. N. M. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20952 · Cited by 14
Chromosome Imbalances in Cancer: Molecular Cytogenetics Meets Genomics
Palumbo, E., & Russo, A. (2016) · Cytogenetic and Genome Research · doi:10.1159/000455804 · Cited by 14
Frequent homozygous deletions of the CDKN2A locus in somatic cancer tissues
Hamid, A. B., Petreaca, B., & Petreaca, R. C. (2019) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2019.04.002 · Cited by 14
A CRISPR-del-based pipeline for complete gene knockout in human diploid cells
Komori, T., Hata, S., Mabuchi, A., Genova, M., Harada, T., Fukuyama, M., Chinen, T., & Kitagawa, D. (2023) · Journal of Cell Science · doi:10.1242/jcs.260000 · Cited by 12
A decision-theoretic approach for segmental classification
Yau, C., & Holmes, C. C. (2013) · The Annals of Applied Statistics · doi:10.1214/13-aoas657 · Cited by 14
Precise inference of copy number alterations in tumor samples from SNP arrays
Chen, G. K., Chang, X., Curtis, C. N., & Wang, K. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt521 · Cited by 14
Scrimieri, F., Calhoun, E. S., Patel, K. G., Gupta, R., Huso, D. L., Hruban, R. H., & Kern, S. E. (2011) · Oncotarget · doi:10.18632/oncotarget.220 · Cited by 14
Reconstructing Breakage Fusion Bridge Architectures Using Noisy Copy Numbers
Zakov, S., & Bafna, V. (2015) · Journal of Computational Biology · doi:10.1089/cmb.2014.0166 · Cited by 11
Bmi-1 is essential for the oncogenic potential in CD133+ human laryngeal cancer cells
Wei, X., He, J., Wang, J., Yang, X., & Ma, B. (2015) · Tumor Biology · doi:10.1007/s13277-015-3541-9 · Cited by 14
Novel patterns of complex structural variation revealed across thousands of cancer genome graphsPreprint
Hadi, K., Yao, X., Behr, J. M., Deshpande, A. S., Xanthopoulakis, C., Rosiene, J. A., Darmofal, M., Tian, H., DeRose, J., Mortensen, R., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/836296 · Cited by 14
Exploring replication stress and cellular senescence as key targets in novel cancer therapies
Ray, S. K., & Mukherjee, S. (2025) · Cancer Genetics · doi:10.1016/j.cancergen.2025.09.002 · Cited by 14
C9orf72 repeat expansion creates the unstable folate-sensitive fragile site FRA9A
Mirceta, M., Schmidt, M. H. M., Shum, N., Prasolava, T., Meikle, B., Lanni, S., Mohiuddin, M., McKeever, P. M., Zhang, M., Liang, M., et al. (2024) · NAR Molecular Medicine · doi:10.1093/narmme/ugae019 · Cited by 15
Emerging frontiers in pancreatic cancer research
Kumar‐Sinha, C., Wei, I. H., & Simeone, D. M. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283567f69 · Cited by 14
Remarkably Long-Tract Gene Conversion Induced by Fragile Site Instability inSaccharomyces cerevisiae
Chumki, S. A., Dunn, M. K., Coates, T., Mishler, J., Younkin, E. M., & Casper, A. M. (2016) · Genetics · doi:10.1534/genetics.116.191205 · Cited by 13
Bester, A. C., Kafri, M., Maoz, K., & Kerem, B. (2013) · Scientific Reports · doi:10.1038/srep02189 · Cited by 14
Haploinsufficient Gene Selection in Cancer
Greenman, C. (2012) · Science · doi:10.1126/science.1224806 · Cited by 13
Self-citationGenetic instability of the tumor suppressor gene FHIT in normal human cells
Palumbo, E., Tosoni, E., Matricardi, L., & Russo, A. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22079 · Cited by 13
Effect of low doses of estradiol and tamoxifen on breast cancer cell karyotypes
Rondón‐Lagos, M., Rangel, N., di Cantogno, L. V., Annaratone, L., Castellano, I., Russo, R. I. C., Manetta, T., Marchiò, C., & Sapino, A. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0078 · Cited by 13
Practical clues for diagnosing WWOX encephalopathy
Tarta‐Arsene, O., Bârcă, D., Craiu, D., & Iliescu, C. (2017) · Epileptic Disorders · doi:10.1684/epd.2017.0924 · Cited by 13
Mason, B., Flach, S., Teixeira, F. R., García, R. M., Rueda, O. M., Abraham, J., Caldas, C., Edwards, P. A., & Laman, H. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03306-y · Cited by 12
Araújo, A. N., Camacho, C. P., Mendes, T. B., Lindsey, S. C., Moraes, L. D. S., Miyazawa, M., Delcelo, R., Pellegrino, R., Mazzotti, D. R., Maciel, R. M. B., et al. (2021) · Cancers · doi:10.3390/cancers13020218 · Cited by 14
Signatures of Discriminative Copy Number Aberrations in 31 Cancer Subtypes
Gao, B., & Baudis, M. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.654887 · Cited by 15
Dreidax, D., Gogolin, S., Schroeder, C., Muth, D., Brueckner, L. M., Hess, E. M., Zapatka, M., Theißen, J., Fischer, M., Ehemann, V., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt020 · Cited by 13
Kołat, D., Kałuzińska‐Kołat, Ż., Bednarek, A. K., & Płuciennik, E. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.621060 · Cited by 12
Meta‑analysis of the autophagy‑associated protein LC3 as a prognostic marker in colorectal cancer
Shen, N., Wang, L., Wu, J., Chen, X., Hu, F., & Su, Y. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.12191 · Cited by 12
Insights into common fragile site instability: DNA replication challenges at DNA repeat sequences
Sinai, M. I., & Kerem, B. (2023) · Emerging Topics in Life Sciences · doi:10.1042/etls20230023 · Cited by 11
Brueckner, L. M., Hess, E. M., Schwab, M., & Savelyeva, L. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.04.007 · Cited by 12
Allelic Imbalance at an 8q24 Oncogenic SNP is Involved in Activating MYC in Human Colorectal Cancer
Sugimachi, K., Niida, A., Yamamoto, K., Shimamura, T., Imoto, S., Iinuma, H., Shinden, Y., Eguchi, H., Sudo, T., Watanabe, M., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3468-6 · Cited by 13
Integrated genomics of ovarian xenograft tumor progression and chemotherapy response
Stuckey, A. R., Fischer, A. K., Miller, D. H., Hillenmeyer, S., Kim, K. K., Ritz, A., Singh, R. K., Raphael, B. J., Brard, L., & Brodsky, A. S. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-308 · Cited by 12
Variant biomarker discovery using mass spectrometry-based proteogenomics
Reilly, L., Seddighi, S., Singleton, A., Cookson, M., Ward, M. E., & Qi, Y. A. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1191993 · Cited by 13
What history tells us XXVIII. What is really new in the current evolutionary theory of cancer?
Morange, M. (2012) · Journal of Biosciences · doi:10.1007/s12038-012-9235-1 · Cited by 13
Homeobox protein VentX induces p53-independent apoptosis in cancer cells
Gao, H., Wu, B., Le, Y., & Zhu, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.9238 · Cited by 12
QuaDMutNetEx: a method for detecting cancer driver genes with low mutation frequency
Bokhari, Y., Alhareeri, A. A., & Arodź, T. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-3449-2 · Cited by 12
Paz, J. S. D., Stronghill, P. E., Douglas, S. J., Saravia, S., Hasenkampf, C. A., & Riggs, C. D. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003136 · Cited by 12
The expanding role of epigenetics
Kalozoumi, G., Tzimas, C., & Sanoudou, D. (2012) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2012.7 · Cited by 12
EZH2 orchestrates apicobasal polarity and neuroepithelial cell renewal
Akizu, N., & Martínez‐Balbás, M. A. (2016) · Neurogenesis · doi:10.1080/23262133.2016.1250034 · Cited by 12
Mazzagatti, A., Shaikh, N., Bakker, B., Spierings, D. C. J., Wardenaar, R., Maniati, E., Wang, J., Boemo, M. A., Foijer, F., & McClelland, S. E. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/743658 · Cited by 12
Jiang, Y., Wu, Y., Zhang, L., Wang, Y., Xu, G., Deng, Y., Han, L., Li, E., Ma, Q., Xu, M., et al. (2023) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbad030 · Cited by 11
seqCNA: an R package for DNA copy number analysis in cancer using high-throughput sequencing
Mosén-Ansorena, D., Tellería, N., Veganzones, S., de la Orden, V., Maestro, M. L., & Aransay, A. M. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-178 · Cited by 11
Sivadas, V. P., Gulati, S., Varghese, B. T., Balan, A., & Kannan, S. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.05.004 · Cited by 11
A general calculus of fitness landscapes finds genes under selection in cancersPreprint
Hsu, T., Asmussen, J. K., Koire, A. M., Choi, B., Gadhikar, M. A., Huh, E., Lin, C.-H., Konecki, D. M., Kim, Y. W., Pickering, C. R., et al. (2022) · Genome Research · doi:10.1101/gr.275811.121 · Cited by 11
Das, M., Hile, S. E., Brewster, J., Boer, J. L., Bezalel‐Buch, R., Guo, Q., Yang, W., Burgers, P., Eckert, K. A., & Freudenreich, C. H. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1254 · Cited by 10
Mutagenesis as a Genetic Research Strategy
Falk, R. (2010) · Genetics · doi:10.1534/genetics.110.120469 · Cited by 10
Zhu, Z., Ihle, N. T., Rejto, P. A., & Zarrinkar, P. P. (2016) · BMC Genomics · doi:10.1186/s12864-016-2807-y · Cited by 10
A Direct Test of Selection in Cell Populations Using the Diversity in Gene Expression within Tumors
Li, C., Hou, Y., Xu, J., Zhang, A., Liu, Z., Qi, F., Yang, Z., Chen, K., Liu, S., Huang, H., et al. (2017) · Molecular Biology and Evolution · doi:10.1093/molbev/msx115 · Cited by 8
Interleukin-12 elicits a non-canonical response in B16 melanoma cells to enhance survival
Byrne-Hoffman, C. N. N., Deng, W., McGrath, O., Wang, P., Rojanasakul, Y., & Klinke, D. J. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00547-4 · Cited by 10
Shibayama, Y., Takahashi, K., Yamaguchi, H., Yasuda, J., Yamazaki, D., Rahman, A., Fujimori, T., Fujisawa, Y., Takai, S., Furukawa, T., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01434-x · Cited by 10
Transflip mutations produce deletions in pancreatic cancer
Norris, A. L., Kamiyama, H., Makohon-Moore, A. P., Pallavajjala, A., Morsberger, L. A., Lee, K., Batista, D., Iacobuzio–Donahue, C. A., Lin, M., Klein, A. P., et al. (2015) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22258 · Cited by 10
Mutant onco-proteins as drug targets: successes, failures, and future prospects
McCormick, F. P. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.12.002 · Cited by 10
Alcalay, R. N., Clark, L. N., Marder, K. S., & Bradley, W. E. C. (2012) · Genes Chromosomes and Cancer · doi:10.1002/gcc.21995 · Cited by 10
Herrmann, A., Haake, A., Ammerpohl, O., Martín‐Guerrero, I., Szafranski, K., STEMSHORN, K. C., Nothnagel, M., Kotsopoulos, S. K., Richter, J., Warner, J. B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021332 · Cited by 10
Nonrandom chromosome abnormalities in cancer
Heim, S., & Mitelman, F. (2015) · Wiley eBooks · doi:10.1002/9781118795569.ch4 · Cited by 10
Cancer-associated chromosomal deletions: Size makes a difference
Cai, Y., & Sablina, A. A. (2016) · Cell Cycle · doi:10.1080/15548627.2016.1204869 · Cited by 10
Evolutionary dynamics in the decades preceding acute myeloid leukaemiaPreprint
Watson, C. J., Poon, G. Y. P., MacGregor, H. A. J., Fonseca, A. V. A., Apostolidou, S., Gentry‐Maharaj, A., Menon, U., & Blundell, J. R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.05.602251 · Cited by 12
Chen, X., Fang, L. T., Chen, Z., Chen, W., Zhu, B., Wu, H., Moos, M. C., Farmer, A. A., Zeng, F., Song, L., et al. (2025) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbaf011 · Cited by 12
Role of common fragile sites and corresponding genes in cancer development
Aqeilan, R. I. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1716-y · Cited by 9
Genome-Wide Identification of Somatic Aberrations from Paired Normal-Tumor Samples
Li, A., Liu, Y., Zhao, Q., Feng, H., Harris, L. N., & Wang, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087212 · Cited by 9
Zhao, Y., & Adjei, A. A. (2014) · Progress in tumor research · doi:10.1159/000355895 · Cited by 9
Fhit loss‐associated initiation and progression of neoplasia in vitro
Karras, J. R., Schrock, M. S., Batar, B., Zhang, J., Perle, K. L., Druck, T., & Huebner, K. (2016) · Cancer Science · doi:10.1111/cas.13032 · Cited by 9
Torabi, K., Erola, P., Álvarez‐Mora, M. I., Díaz‐Gay, M., Ferrer, Q., Castells, A., Castellvı́-Bel, S., Milà, M., Lozano, J. J., Miró, R., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31936 · Cited by 9
Transcription–Replication Coordination
Saponaro, M. (2022) · Life · doi:10.3390/life12010108 · Cited by 9
QuaDMutEx: quadratic driver mutation explorer
Bokhari, Y., & Arodz, T. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1869-4 · Cited by 10
Eradication of ENO1 -deleted Glioblastoma through Collateral LethalityPreprint
Lin, Y.-H., Satani, N., Hammoudi, N., Ackroyd, J. J., Khadka, S., Yan, V. C., Georgiou, D. K., Sun, Y., Zielinski, R. J., Tran, T. T., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/331538 · Cited by 9
Delayed DNA replication in haploid human embryonic stem cellsPreprint
Edwards, M. M., Zuccaro, M. V., Sagi, I., Ding, Q., Vershkov, D., Benvenisty, N., Egli, D. M., & Koren, A. (2021) · Genome Research · doi:10.1101/gr.275953.121 · Cited by 9
Co-dependent regulation of p-BRAF and potassium channel KCNMA1 levels drives glioma progression
Xie, S., Xu, C., Wu, C., Lou, Y., Duan, J., Sang, R., Lou, Z., Hou, J., Ge, W., Xi, Y., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04708-9 · Cited by 8
Handa, H., Sasaki, Y., Hattori, H., Alkebsi, L., Kasamatsu, T., Saitoh, T., Mitsui, T., Yokohama, A., Tsukamoto, N., Matsumoto, M., et al. (2017) · Oncology Letters · doi:10.3892/ol.2017.6672 · Cited by 8
3D Culture Modelling: An Emerging Approach for Translational Cancer Research in Sarcomas
Heredia-Soto, V., Redondo, A., Pozo‐Kreilinger, J. J., Martínez-Marín, V., Berjón, A., & Mendiola, M. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666191212162102 · Cited by 7
Loss of Heterozygosity and Copy Number Alterations in Flow-Sorted Bulky Cervical Cancer
van den Tillaart, S. A. H. M., Corver, W. E., Ruano, D., ter Haar, N. T., Goeman, J. J., Trimbos, J. B., Fleuren, G. J., & Oosting, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067414 · Cited by 8
Developing Algorithms to Discover Novel Cancer Genes: A look at the challenges and approaches
Saksena, G., Mermel, C. H., & Getz, G. A. (2011) · IEEE Signal Processing Magazine · doi:10.1109/msp.2011.943011 · Cited by 8
Kołat, D., Kałuzińska‐Kołat, Ż., Bednarek, A. K., & Płuciennik, E. (2021) · Cancers · doi:10.3390/cancers13122957 · Cited by 8
Metadata
- Authors
- Bignell, G. R., Greenman, C. D., Davies, H., Butler, A. P., Edkins, S., Andrews, J. M., Buck, G., Chen, L., Beare, D., Latimer, C., Widaa, S., Hinton, J., Fahey, C., Fu, B., Swamy, S., Dalgliesh, G. L., Teh, B. T., Deloukas, P., Yang, F., Campbell, P. J., Futreal, P. A., & Stratton, M. R.
- Affiliations
- Wellcome Sanger Institute (GB)
- Van Andel Institute (US)
- Institute of Cancer Research (GB)
- Corresponding author
- Futreal, P. Andrew
- Stratton, Michael R.
- ORCID
- Venue
- Nature
- Published
- 2010-02
- Volume
- 463
- Issue
- 7283
- Pages
- 893-898
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3145113
- OpenAlex
- W2071734901
- Cited by
- 707
- References
- 41
- Citations by year
- 2026: 7 · 2025: 24 · 2024: 21 · 2023: 29 · 2022: 25 · 2021: 32 · 2020: 40 · 2019: 30 · 2018: 44 · 2017: 44 · 2016: 47 · 2015: 48 · 2014: 61 · 2013: 71 · 2012: 76
- FWCI
- 25.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Wellcome Trust (077012/Z/05/Z, 088340, 093867)
- National Cancer Institute (P01CA155258)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- fragile sites, copy number variation, cancer cell lines, structural signatures, DNA breakage, Mcl-1, Bcl-xL, gene amplification, tumor suppressor
- MeSH terms
- Chromosomes, Human, DNA Mutational Analysis, Genes, Recessive, Homozygote, Humans, Models, Genetic, Neoplasms, Selection, Genetic, Reproducibility of Results, Genome, Human, Gene Deletion, Gene Dosage, Physical Chromosome Mapping, Oligonucleotide Array Sequence Analysis, Chromosome Fragile Sites, Cell Line, Tumor, Genes, Neoplasm, DNA Copy Number Variations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
